Aion Therapeutic Inc. (AION.CN)
CAD 0.01
(0.0%)
CAD 0.01
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -6.07 Million CAD | N/A |
| 2022 | -89.51 Thousand CAD | 61.24% |
| 2021 | -3.67 Million CAD | -3.84% |
| 2020 | -7.95 Million CAD | -199.45% |
| 2019 | -240.59 Thousand CAD | 47.93% |
| 2018 | -3.44 Million CAD | -1197.53% |
| 2017 | -131.07 Thousand CAD | -7.51% |
| 2016 | -121.92 Thousand CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q3 | -224.26 Thousand CAD | 15.59% |
| 2023 Q1 | -165.3 Thousand CAD | 40.6% |
| 2023 Q2 | -265.69 Thousand CAD | -60.73% |
| 2022 Q1 | -326.2 Thousand CAD | 76.87% |
| 2022 Q3 | -241.12 Thousand CAD | -8.82% |
| 2022 Q2 | -221.58 Thousand CAD | 32.07% |
| 2022 Q4 | -278.29 Thousand CAD | -15.42% |
| 2022 FY | - CAD | 61.24% |
| 2021 FY | - CAD | -3.84% |
| 2021 Q4 | -1.41 Million CAD | -322.58% |
| 2021 Q3 | -333.74 Thousand CAD | 41.58% |
| 2021 Q2 | -571.32 Thousand CAD | -30.38% |
| 2021 Q1 | -438.21 Thousand CAD | 58.94% |
| 2020 Q1 | -426.74 Thousand CAD | -102.59% |
| 2020 Q3 | -503.81 Thousand CAD | 22.99% |
| 2020 Q2 | -654.19 Thousand CAD | -53.3% |
| 2020 FY | - CAD | -199.45% |
| 2020 Q4 | -1.06 Million CAD | -111.81% |
| 2019 Q1 | -328.55 Thousand CAD | 30.91% |
| 2019 Q2 | -173.71 Thousand CAD | 47.13% |
| 2019 Q3 | -172.67 Thousand CAD | 0.6% |
| 2019 Q4 | -210.64 Thousand CAD | -21.99% |
| 2019 FY | - CAD | 47.93% |
| 2018 Q2 | -673.39 Thousand CAD | -226.34% |
| 2018 FY | - CAD | -1197.53% |
| 2018 Q4 | -475.55 Thousand CAD | -37.66% |
| 2018 Q3 | -345.46 Thousand CAD | 48.7% |
| 2018 Q1 | -206.34 Thousand CAD | 30.45% |
| 2017 Q4 | -296.7 Thousand CAD | -2966900.0% |
| 2017 FY | - CAD | -7.51% |
| 2017 Q2 | -17.51 Thousand CAD | 0.0% |
| 2017 Q3 | -10.00 CAD | 99.94% |
| 2016 FY | - CAD | 0.0% |
| 2015 Q3 | -5978.00 CAD | 0.0% |
| 2015 Q1 | -5996.00 CAD | 0.0% |
| 2014 Q3 | -6274.00 CAD | 0.0% |
| 2014 Q1 | -4978.00 CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Ayurcann Holdings Corp. | -2.01 Million CAD | -202.1% |
| Blueberries Medical Corp. | -1.22 Million CAD | -397.115% |
| The BC Bud Corporation | -1.19 Million CAD | -407.828% |
| BioNxt Solutions Inc. | -6.48 Million CAD | 6.337% |
| CordovaCann Corp. | -1.6 Million CAD | -278.986% |
| Christina Lake Cannabis Corp. | -2.62 Million CAD | -131.516% |
| Captor Capital Corp. | 2.42 Million CAD | 350.858% |
| City View Green Holdings Inc. | -2.01 Million CAD | -201.505% |
| 1CM Inc. | 1.31 Million CAD | 562.396% |
| Global Hemp Group Inc. | -24.79 Thousand CAD | -24397.632% |
| Greenway Greenhouse Cannabis Corporation | -2.2 Million CAD | -175.028% |
| IM Cannabis Corp. | -2.79 Million CAD | -117.695% |
| Lobe Sciences Ltd. | -4.4 Million CAD | -37.967% |
| Maple Leaf Green World Inc. | -392.21 Thousand CAD | -1448.559% |
| Mountain Valley MD Holdings Inc. | -3.19 Million CAD | -90.219% |
| Nextleaf Solutions Ltd. | 1.14 Million CAD | 632.033% |
| Ovation Science Inc. | -778.83 Thousand CAD | -679.847% |
| Pharmadrug Inc. | -1.33 Million CAD | -354.954% |
| Captiva Verde Wellness Corp. | -6.05 Million CAD | -0.291% |
| RAMM Pharma Corp. | -6.3 Million CAD | 3.624% |
| RIV Capital Inc. | -20.28 Million CAD | 70.051% |
| Revive Therapeutics Ltd. | -5.59 Million CAD | -8.556% |
| Red White & Bloom Brands Inc. | -77.59 Million CAD | 92.172% |
| SLANG Worldwide Inc. | -2.95 Million CAD | -105.838% |
| 1933 Industries Inc. | -10.03 Million CAD | 39.463% |
| Red Light Holland Corp. | -5.25 Million CAD | -15.561% |
| Top Strike Resources Corp. | -767.99 Thousand CAD | -690.853% |
| Xebra Brands Ltd. | -1.49 Million CAD | -306.269% |
| Adastra Holdings Ltd. | -1.41 Million CAD | -330.373% |